BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35885491)

  • 41. Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis.
    Yi C; Li J; Tang F; Ning Z; Tian H; Xiao L; Wang A; Zong Z
    Am Surg; 2020 May; 86(5):499-507. PubMed ID: 32684032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Factors in Stage IV Colorectal Cancer Patients With Resection of Liver and/or Pulmonary Metastases: A Population-Based Cohort Study.
    Peng P; Luan Y; Sun P; Wang L; Zeng X; Wang Y; Cai X; Ren P; Yu Y; Liu Q; Ma H; Chang H; Song B; Fan X; Chen Y
    Front Oncol; 2022; 12():850937. PubMed ID: 35372009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
    Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
    J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
    Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
    Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
    Sanford NN; Folkert MR; Aguilera TA; Beg MS; Kazmi SA; Sanjeevaiah A; Zeh HJ; Farkas L
    Am J Clin Oncol; 2020 Dec; 43(12):850-856. PubMed ID: 32976176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
    Tsilimigras DI; Hyer JM; Paredes AZ; Ejaz A; Cloyd JM; Beane JD; Dillhoff M; Tsung A; Pawlik TM
    J Gastrointest Surg; 2021 Sep; 25(9):2368-2376. PubMed ID: 33403563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary tumor location impacts survival in colorectal cancer patients after primary resection: a population‑based propensity score matching cohort study.
    Yin H; Li H; Xu J; Wu J
    J Gastrointest Oncol; 2023 Apr; 14(2):886-899. PubMed ID: 37201082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
    Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis.
    Huang L; Wei G; Chen N; Liu J; Wang Z; Yu Y; Qiu M
    Clin Med Insights Oncol; 2022; 16():11795549221085054. PubMed ID: 35355515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resection of the primary tumor improves the prognosis of gastrointestinal neuroendocrine neoplasms with liver metastases: mutual validation based on SEER database and institutional data.
    Liu Y; Wang Z; Lin Q; Cui R; Tang W; Li G; Wang Z
    BMC Gastroenterol; 2023 Nov; 23(1):408. PubMed ID: 37993767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.
    Ruo L; Gougoutas C; Paty PB; Guillem JG; Cohen AM; Wong WD
    J Am Coll Surg; 2003 May; 196(5):722-8. PubMed ID: 12742204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between Primary Tumor Resection for Metastatic Small Intestine Neuroendocrine Tumors and Survival: A Propensity Score-Matched Analysis.
    Yan H; Yin L; Han H; Jin Y; Liu Z
    J Invest Surg; 2022 Jun; 35(6):1239-1247. PubMed ID: 34991432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.
    van der Kruijssen DEW; van Rooijen KL; Kurk SA; de Wilt JHW; Punt CJA; Vink GR; Elias SG; Koopman M
    Dig Surg; 2021; 38(4):283-289. PubMed ID: 34320508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
    Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
    J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    Stelzner S; Radulova-Mauersberger O; Zschuppe E; Kittner T; Abolmaali N; Puffer E; Zimmer J; Witzigmann H
    J Surg Oncol; 2019 Sep; 120(3):438-445. PubMed ID: 31168858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
    Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
    Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
    Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
    Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.
    Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study.
    Li X; Huang H; Ran L; Fang C; Yu Y; Luo M; Qiu M
    Cancer Manag Res; 2020; 12():4493-4501. PubMed ID: 32606943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.